New MRI method could spare thousands from unnecessary kidney surgery
NCT ID NCT03470285
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study tested whether a special type of MRI (multiparametric MRI) can accurately tell the difference between benign and malignant small kidney tumors. About 387 adults with small solid kidney masses (1.5-4 cm) were scanned before surgery or biopsy. The goal was to see if the MRI could reliably identify benign tumors, potentially allowing some patients to avoid unnecessary surgery. The study involved 18 centers and multiple radiologists to check consistency.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Multiparametric MR imaging (mpMRI)
What this could lead to
If successful, mpMRI could help doctors decide which small kidney tumors need surgery and which can be safely monitored, reducing unnecessary operations.
What could go wrong
This is a completed diagnostic accuracy study, not a treatment trial. The MRI technique may not be accurate enough in all cases, and results depend on radiologist interpretation.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
APHM - Hôpital de la Conception
Marseille, 13385, France
-
APHP - Henri Mondor
Créteil, 94010, France
-
APHP - Hôpital Bichat
Paris, France
-
APHP - Hôpital Bicêtre
Le Kremlin-Bicêtre, 94275, France
-
APHP - Hôpital Necker
Paris, 75743, France
-
APHP - Hôpital Tenon
Paris, 75020, France
-
CHRU Lille
Lille, 59000, France
-
CHU Angers
Angers, 49933, France
-
CHU Bordeaux
Bordeaux, 33076, France
-
CHU Lyon
Lyon, 69444, France
-
CHU Nancy
Nancy, 54511, France
-
CHU Nice
Nice, 06001, France
-
CHU Rennes
Rennes, 35033, France
-
CHU Rouen
Rouen, 76031, France
-
CHU Strasbourg
Strasbourg, 67091, France
-
CHU Toulouse
Toulouse, 31062, France
-
CHU Tours
Tours, 37044, France
-
CHU de Grenoble
Grenoble, France